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ABSTRACT 20 
Bacteria and many non-metazoan Eukaryotes respond to stresses and threats 21 
using two-component systems (TCSs) comprising sensor kinases (SKs) and 22 
response regulators (RRs). Multikinase networks, where multiple SKs work 23 
together, detect and integrate different signals to control important lifestyle 24 
decisions such as sporulation and virulence. Here, we study interactions 25 
between two SKs from Pseudomonas aeruginosa, GacS and RetS, which 26 
control the switch between acute and chronic virulence. We demonstrate three 27 
mechanisms by which RetS attenuates GacS signalling: RetS takes 28 
phosphoryl groups from GacS-P; RetS has transmitter phosphatase activity 29 
against the receiver domain of GacS-P; and RetS inhibits GacS 30 
autophosphorylation. These mechanisms play important roles in vivo and 31 
during infection, and exemplify an unprecedented degree of signal processing 32 
by SKs that may be exploited in other multikinase networks.   33 
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INTRODUCTION 34 
Canonical TCSs, comprising a single SK working with its cognate RR1,2, detect and 35 
respond to stimuli but are not well suited to making complex decisions requiring the 36 
integration of multiple signals. However, multikinase-networks, where several SKs 37 
collaborate to detect and integrate signals, can make these sophisticated decisions 38 
requiring the evaluation of multiple stimuli. Multikinase networks regulate processes 39 
as diverse as asymmetric cell division3-5, sporulation6, chemotaxis7, nitrogen 40 
metabolism8, stress responses9, virulence10,11, biofilm formation12, and differentiation 41 
into fruiting bodies13,14. Many multikinase networks feature interactions between their 42 
constituent SKs but how they affect signalling output is unclear15-17.  43 
Most SKs are homodimeric proteins, containing sensory domains for detecting 44 
stimuli and controlling the activity of their catalytic core, comprising the HisKA and 45 
HATPase domains. The HATPase domain binds ATP and phosphorylates a histidine 46 
residue within the HisKA domain. For simple SKs, following autophosphorylation, 47 
phosphotransfer occurs to an aspartate in the receiver (REC) domain of the RR. In 48 
more complex SKs (~20% of bacterial and ~90% of eukaryotic examples), additional 49 
phosphorylation sites, contained within either attached REC (hybrid SKs) or attached 50 
REC and Hpt domains (unorthodox SKs)18, participate in multi-step phosphorelays, 51 
which comprise His-to-Asp and Asp-to-His phosphotransfer reactions, conveying 52 
phosphoryl groups to the RR. Phosphorylation activates the RR, mediating a 53 
response to the stimulus19. Signals are terminated by hydrolysis of the aspartyl-54 
phosphate residue, which is an autocatalytic process, often augmented by either 55 
transmitter phosphatase activity of the SK or extrinsic phosphatases20-22. The 56 
phosphotransfer and phosphatase reactions are highly specific, ensuring fidelity of 57 
signalling23-29.  58 
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Pseudomonas aeruginosa is a leading cause of healthcare-acquired-59 
infections30,31. It infects vulnerable patients e.g. neonates or those with cystic 60 
fibrosis, burn wounds or cancer. It causes acute and chronic infections32; acute 61 
infections (e.g. pneumonia and sepsis) feature motility and type III secretion (T3S), 62 
while, chronic infections (e.g. cystic fibrosis lung) involve biofilm production and type 63 
VI secretion (T6S)32-34. The GacS multikinase-network plays a key role in 64 
orchestrating the transition between acute and chronic infection35-38. Central to this 65 
network is the unorthodox SK, GacS, which phosphorylates the RR, GacA. GacA-P 66 
activates transcription of the regulatory RNAs, RsmY & RsmZ, which sequester the 67 
translational regulator, RsmA, thereby upregulating genes required for chronic 68 
infection and downregulating acute infection39-43.  69 
Although only GacS-P phosphorylates GacA, other SKs influence GacA-P 70 
levels via GacS.  LadS senses calcium44, and promotes chronic infection by 71 
phosphorylating GacS45,46. In contrast, the hybrid SK, RetS, binds and inhibits GacS 72 
via unknown mechanisms, favouring acute infection10,47-49. The ligand controlling 73 
RetS is unknown, but RetS responds to lysis of kin P. aeruginosa cells50. Another 74 
SK, PA1611, sequesters RetS, relieving GacS from its inhibition51,52.  75 
The inhibitory interaction of RetS with GacS is considered the paradigm for 76 
negative regulation in multikinase-networks10. Previously, it was proposed that they 77 
form an inactive heterodimer incapable of autophosphorylation10.  Here, we 78 
demonstrate the interactions are much more extensive, with RetS having three 79 
distinct mechanisms for downregulating GacS. All are important for RetS function 80 
and play major roles in virulence. These mechanisms represent an unprecedented 81 
level of cross-communication between SKs that can be widely utilised by other 82 
multikinase-networks. 83 
84 
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Results 85 
RetS takes phosphoryl groups from GacS-P in mechanism 1. RetS has a 86 
degenerate HATPase domain lacking the conserved G-boxes and consequently is 87 
unable to autophosphorylate. The cytoplasmic portions of GacS and RetS (denoted 88 
GacSc and RetSc) interact, and the inclusion of RetSc in GacSc 89 
autophosphorylation reactions reduces the steady-state levels of GacSc-P 90 
produced10; here, we determine the molecular mechanisms responsible. We began 91 
by testing whether RetSc could accelerate the dephosphorylation of purified GacSc-92 
P (Fig. 1a,b); these reactions did not contain any residual ATP. We detected 93 
phosphorylation of RetSc (Fig. 1b), indicating phosphotransfer had occurred from 94 
GacSc-P to RetSc. To determine which of the three phosphorylation sites of RetS 95 
accepts the phosphoryl group from GacS-P, we prepared mutant RetSc proteins 96 
lacking these sites (wild-type RetSc, with its three native phosphorylation sites is 97 
denoted RetSc(HDD)). The mutant protein lacking the phosphorylation site in REC1 98 
(D713) was unchanged in its ability to be phosphorylated by GacSc-P 99 
(Supplementary Fig. 1). We found that the mutant proteins lacking the 100 
phosphorylation site in REC2 (D858), RetSc(HDA) and RetSc(HAA), were not 101 
phosphorylated by GacSc-P (Fig. 1c,d), indicating that D858 is phosphorylated by 102 
GacSc-P. 103 
To identify which of the three phosphorylation sites of GacSc-P was the 104 
phosphodonor for this phosphotransfer reaction, we engineered a mutant GacSc 105 
protein, GacSc(HAQ), retaining only its autophosphorylation site and lacking its REC 106 
and Hpt domain phosphorylation sites. We found that when purified GacSc(HAQ)-P 107 
was coincubated with RetSc, RetSc-P was produced and the intensity of the 108 
GacSc(HAQ)-P band was decreased, meaning that phosphotransfer had occurred 109 
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from GacSc(HAQ)-P to RetSc (Fig. 1f). RetSc-P levels did not rise to the same 110 
extent as GacSc(HAQ)-P levels decreased during this phosphotransfer reaction 111 
because RetSc-P dephosphorylates and therefore RetSc-P levels are determined 112 
not only by the rate of phosphotransfer from GacSc(HAQ)-P but also by how quickly 113 
RetSc-P dephosphorylates.  No phosphotransfer was seen from GacSc(HAQ)-P to 114 
the mutant RetSc proteins lacking D858, RetSc(HDA) and RetSc(HAA) (Fig. 1g,h). 115 
These data indicate that the autophosphorylatable His residue in the HisKA domain 116 
of GacS is a phosphodonor for D858 in REC2 of RetS. We refer to this as 117 
mechanism 1 (Fig. 1i).  118 
RetS is a transmitter phosphatase for GacS-P in mechanism 2. Wild-type 119 
GacSc-P autodephosphorylates with a half-time of 25 ± 2 mins (Fig. 1j,k). RetS 120 
mutant proteins, RetSc(HDA) (Fig. 1g) and RetSc(HAA) (Fig. 1h), lacking D858, are 121 
disabled for mechanism 1 and cannot dephosphorylate GacSc(HAQ)-P. However, 122 
they still speed up the dephosphorylation of wild-type GacSc-P (Fig. 1k); each 123 
reducing the half-time from 25 ± 2 mins to 15 ± 1 mins (Fig. 1k). Likewise, RetSHK, 124 
lacking both REC domains and comprising only the catalytic core (HisKA and the 125 
degenerate HATPase domain) of RetS, also reduced the GacSc-P 126 
dephosphorylation half-time (Fig. 1j,k). This suggests RetS has a second mechanism 127 
for dephosphorylating GacS-P that resides within the catalytic core of RetS, and 128 
targets either the REC or Hpt phosphorylation sites of GacS (present in wild-type 129 
GacSc-P but not in GacSc(HAQ)-P). We examined the dephosphorylation of 130 
GacSc(HDQ)-P, which lacks the phosphorylation site in the Hpt domain, and found 131 
that RetSc(HDA) and RetSHK could catalyse its dephosphorylation (Supplementary 132 
Fig. 2), indicating that the Hpt phosphorylation site is not the target and therefore the 133 
target is the REC domain phosphorylation site.  134 
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The majority of SKs have kinase and phosphatase activity. While RetS has a 135 
degenerate HATPase domain rendering it incapable of autophosphorylation, its 136 
HisKA domain retains the conserved H-box including the motif (HExxT) needed for 137 
transmitter phosphatase activity20,53. We therefore, hypothesised that RetS has 138 
transmitter phosphatase activity directed towards the REC domain of GacS. 139 
Consistent with this, the mutant protein, RetSc(T428A,HDA), lacking both the 140 
conserved T428 residue from the HExxT phosphatase motif, and D858 required for 141 
mechanism 1, had no ability to speed up GacSc-P dephosphorylation (Fig. 1k). 142 
Therefore, mechanism 2 is enhanced dephosphorylation of GacS-P by transmitter 143 
phosphatase activity of RetS against the REC domain of GacS (Fig. 1l).        144 
RetS inhibits the autophosphorylation of GacS in mechanism 3. Mechanisms 1 145 
and 2, described above, dephosphorylate GacS-P. Here we tested whether RetS 146 
could affect the autophosphorylation rate of GacS; we did this using mutant versions 147 
of GacSc and RetSc where both dephosphorylation mechanisms were disabled. 148 
RetSc(HAA) cannot dephosphorylate GacSc(HAQ)-P (Fig. 1h); however, the 149 
presence of RetSc(HAA) in a GacSc(HAQ) autophosphorylation reaction, reduced 150 
the level of GacSc(HAQ)-P that accumulated (Fig. 1m). Likewise, 151 
RetSc(T428A,HDA) which is disabled for mechanisms 1 and 2 (Fig. 1k), inhibited the 152 
autophosphorylation of GacSc(HAQ) (Fig. 1m). Similar results were seen when using 153 
only the kinase catalytic cores (HisKA and HATPase domain) of GacS and RetS; the 154 
presence of RetSHK in a GacSHK autophosphorylation reaction, reduced the level of 155 
GacSHK-P that accumulated (Fig. 1n). This means there is a third mechanism of 156 
interaction between GacS and RetS where the kinase core of RetS inhibits 157 
autophosphorylation of GacS (Fig. 1o).   158 
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Mechanisms 1 and 2 control biofilm formation. To determine the relative 159 
contribution of the three mechanisms in vivo, we replaced the wild-type retS gene in 160 
the chromosome with mutant versions; the retS(HDA) mutant lacking mechanism 1, 161 
the retS(T428A) mutant lacking mechanism 2, the retS(T428A,HDA) mutant lacking 162 
mechanisms 1 and 2, and the ∆retS mutant lacking all three mechanisms. We 163 
confirmed that the mutant proteins were expressed at comparable levels to wild-type 164 
RetS by western blotting (Supplementary Note 1 and Supplementary Fig. 3). 165 
Deletion of retS enhances biofilm formation (Fig. 2)47,48,54. The retS point 166 
mutants (retS(HDA), retS(T428A) and retS(T428A,HDA)) produced significantly more 167 
biofilm than the PAO1 strain (Fig. 2a). The mutant lacking mechanism 1, retS(HDA), 168 
had similar biofilm levels to the ΔretS mutant, indicating that mechanism 1 plays a 169 
major role in regulating biofilm formation. While biofilm levels were significantly 170 
higher in the retS(T428A) mutant than in the wild-type strain, they were not elevated 171 
to the same extent as the ΔretS mutant, indicating that mechanism 2 plays a 172 
significant role in controlling biofilm formation although to a lesser extent than 173 
mechanism 1. To verify that the increased biofilm formation observed in the retS 174 
point mutants was a consequence of GacS dysregulation, we introduced these 175 
mutations into a ΔgacS background. Like their parent ∆gacS mutant, these double 176 
gacS/retS mutants produced significantly less biofilm than the PAO1 strain 177 
(Supplementary Fig. 4), consistent with the retS point mutations affecting signalling 178 
via GacS. These data indicate that the control of GacS signalling by mechanisms 1 179 
and 2 of RetS are important for regulating biofilm formation. 180 
Contribution of the three mechanisms to controlling RsmY&Z. The GacS 181 
network controls the expression of two small RNAs, RsmY and RsmZ55. The ∆retS 182 
mutant has elevated levels of RsmY and RsmZ because of its increased GacS 183 
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activity10,55,56. We found that levels of RsmY and RsmZ were increased in all retS 184 
point mutant strains lacking mechanisms 1 and 2 (Fig. 2b,c), indicating that these 185 
mechanisms play major roles in controlling rsmY and rsmZ expression. The mutant 186 
lacking both mechanisms 1 and 2 (retS(T428A,HDA)), however, did not produce as 187 
much RsmZ as the ∆retS mutant (Fig. 2c), suggesting that mechanism 3, alongside 188 
mechanisms 1 and 2, contributes a significant role to controlling the expression of 189 
rsmZ. 190 
Mechanism 1 is important for swarming motility. Unlike the wild-type strain, 191 
PAO1, the ∆retS mutant did not swarm (Fig. 3). We found that all mutants lacking 192 
mechanism 1, e.g. retS(HDA) (Fig. 3b) were unable to swarm, indicating that 193 
mechanism 1 is essential. The mutant lacking mechanism 2, retS(T428A), did 194 
swarm, indicating that mechanism 2 is not required (Fig. 3c).  195 
Virulence in Galleria mellonella requires mechanisms 1 and 2. To assess the 196 
role of the three mechanisms in virulence, the retS mutants were tested in a Galleria 197 
mellonella infection model. Larvae were injected with 20-40 CFUs of PAO1 or mutant 198 
strains. The PAO1 infected larvae all died within 21 hours of infection, whereas over 199 
60 % of the larvae infected with the ∆retS mutant survived to the end of the 200 
experiment (47 hours post-infection) (Fig. 4a). Similar to the ΔretS mutant, the 201 
retS(HDA) and retS(T428A,HDA) mutants showed severely attenuated virulence with 202 
significantly more larvae surviving than those infected with PAO1 (Fig. 4a). The 203 
retS(T428A) mutant showed significantly delayed killing compared to those infected 204 
with PAO1 (Fig. 4a). We examined the phenotypes of the retS(HDA)ΔgacS and the 205 
retS(T428A)ΔgacS mutants and found that they were as virulent as the ΔgacS 206 
mutant (Fig. 4b), confirming that the reduction in virulence seen in the retS(HDA) and 207 
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retS(T428A) mutants were dependent on the presence of GacS and therefore a 208 
consequence of GacS dysregulation. In summary, mechanism 1 is essential for 209 
virulence in G. mellonella whereas loss of mechanism 2 delays killing.  210 
RetS overexpression allows mechanism 3 to support virulence. The mutant 211 
lacking mechanisms 1 and 2, retS(T428A,HDA), phenocopies the ΔretS mutant in 212 
most of the above assays, with the only significant difference being that RsmZ levels 213 
are not elevated to the same extent as the ΔretS mutant (Fig. 2c).  This indicates that 214 
mechanism 3 alone is not sufficient for RetS function, and that dephosphorylation of 215 
GacS-P, via mechanisms 1 and 2, is essential. We hypothesised that while 216 
mechanism 3 cannot compensate for the loss of mechanisms 1 and 2 at native 217 
expression levels of RetS, it may be able to compensate at higher expression levels. 218 
To test this, we overexpressed RetS(T428A,HDA), which possesses only 219 
mechanism 3, in the ΔretS mutant. Successful complementation was seen (Fig. 4c) 220 
indicating that, at non-physiologically high expression levels, mechanism 3 221 
compensates for the loss of mechanisms 1 and 2.  However, at physiological 222 
expression levels of RetS, this compensation cannot occur, and mechanisms 1 and 223 
2 are both required. 224 
Mechanisms 1 and 2 are required for virulence in mice. We used a mouse model 225 
of acute respiratory infection to probe the role of the mechanisms in virulence. Mice 226 
were inoculated intranasally with 2 x 107 CFUs of P. aeruginosa. Only 10% of mice 227 
infected with PAO1 survived beyond 28 hours of infection. All mice infected with the 228 
ΔretS mutant or the mutant lacking mechanism 1 (retS(HDA)) survived for the seven-229 
day duration of the experiment, demonstrating that RetS and mechanism 1 are 230 
essential for virulence (Fig. 5). The retS(T428A) mutant, which lacks mechanism 2, 231 
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was also severely attenuated in virulence with 80% of mice surviving to the endpoint 232 
of the experiment (Fig. 5). These results indicate that mechanisms 1 and 2 are both 233 
important for acute virulence.  234 
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Discussion 235 
We have shown that two SKs, RetS and GacS, which play a major role in controlling 236 
virulence in P. aeruginosa, interact extensively, with RetS having three distinct 237 
mechanisms for downregulating GacS signalling (Fig. 6). In mechanism 1, RetS 238 
takes phosphoryl groups from GacS-P, with phosphotransfer occurring from the 239 
autophosphorylation site of GacS to REC2 of RetS. In mechanism 2, RetS has 240 
transmitter phosphatase activity that speeds up the dephosphorylation of the REC 241 
domain of GacS-P. In mechanism 3, RetS inhibits the autophosphorylation of GacS. 242 
These three mechanisms allow RetS to have exquisite control of GacS signalling 243 
and they all play significant roles in vivo and during infection. In particular, we show 244 
that mechanisms 1 and 2 play vital roles during acute respiratory infection in mice.  245 
This is the first discovery of such an intricate level of interconnectedness and 246 
communication between a pair of SKs in a sensory network. This has profound 247 
implications for other sensory networks employing multiple SKs which, in light of this 248 
study, could be expected to use similar mechanisms of communication to process 249 
sensory data and integrate multiple signals. A further implication is that because of 250 
the increased number of different mechanisms by which kinase-to-kinase signalling 251 
can occur, multikinase networks may be even more widespread than previously 252 
appreciated. 253 
The three mechanisms identified here represent an unprecedented level of 254 
communication between two SKs and there is great potential for them to be 255 
employed in other multikinase networks. Mechanism 1 employs intermolecular 256 
phosphotransfer to signal from the HisKA domain of one SK (GacS) to a REC 257 
domain located within another SK (RetS). Here, REC2 of RetS functions as a 258 
phosphate sink for GacS. As around 20% of SKs have a REC domain (i.e. are 259 
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hybrid/unorthodox), related phosphotransfer mechanisms will be found connecting 260 
many other pairs of kinases that work together12,13,18,46. Mechanism 2 uses the 261 
transmitter phosphatase activity of one SK (RetS) against the REC domain of 262 
another SK (GacS); as far as we are aware, this is the first demonstration of 263 
transmitter phosphatase activity occurring between two kinases but there is wide 264 
potential for it to be employed in other multikinase-networks because almost all SKs 265 
have transmitter phosphatase activity20. Mechanism 3 involves inhibitory interactions 266 
between the catalytic core of two kinases (RetS and GacS)10, and consistent with 267 
this mechanism being used by other networks are the findings of a systematic two-268 
hybrid screen of the SKs from Myxococcus xanthus, which tested 725 possible 269 
catalytic core/catalytic core interactions and found evidence of interaction in over 100 270 
cases16.  271 
Mechanism 1 depends on the phosphorylatable aspartate residue in REC2 of 272 
RetS (D858) and is essential for virulence, biofilm formation, swarming and normal 273 
expression levels of RsmY&Z. Most strikingly, the retS(HDA) mutant, lacking D858, 274 
was completely avirulent in mice (Fig. 5). Prior to our discovery of its key role in 275 
mechanism 1, the role of D858 had been investigated. Similar to our findings with the 276 
PAO1 strain of P. aeruginosa, Laskowski and Kazmierczak found that for the PA103 277 
strain, D858 is essential for RetS function56. However, in contrast, Goodman et al., 278 
found no phenotype for the D858 mutation in the PAK strain10. This suggests that 279 
either of the two remaining mechanisms (which are independent of D858) 280 
compensate when mechanism 1 is lost in the PAK strain but not in the PAO1 and 281 
PA103 strains.  282 
The three mechanisms that we have demonstrated signal via GacS to control 283 
phosphorylation levels of the output RR, GacA, which controls expression of the 284 
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regulatory RNAs, RsmY and RsmZ. Loss of any individual mechanism is sufficient to 285 
increase RsmY expression levels to the same extent as seen in the ΔretS mutant 286 
(Fig. 2b), whereas although significant elevation in RsmZ levels is seen when 287 
individual mechanisms are lost, it is not to the same extent as seen with the ΔretS 288 
mutant (Fig. 2c). RsmY expression has previously been reported to be at least 2-fold 289 
higher than RsmZ expression55,58. These findings can be explained by a model 290 
where GacA-P binds more tightly to the RsmY promoter than to the RsmZ promoter. 291 
Deleting retS, eliminates all three of our mechanisms, thereby giving a large rise in 292 
GacA-P levels, sufficient to fully activate RsmY and RsmZ expression. The retS point 293 
mutations, by disabling individual mechanisms, would generate a rise in GacA-P 294 
levels but not as much as is seen in the retS deletion mutant. This lesser rise in 295 
GacA-P levels would be enough to fully activate the RsmY promoter (due to its 296 
higher binding affinity) but not enough to fully activate the RsmZ promoter.  297 
An intriguing question is why are multiple mechanisms necessary to 298 
orchestrate this virulence switch? Presumably, each mechanism contributes uniquely 299 
to the balance of the decision-making process during infection and the complexity of 300 
this process reflects the importance of the decision to bacterial survival in the host. 301 
Differential regulation of the three mechanisms would allow precise control of GacS 302 
signalling and, given their importance for virulence, it is tempting to speculate that 303 
these elaborate mechanisms constitute a logic gate for processing and integrating 304 
the different stimuli sensed by GacS and RetS to decide the course of the infection. 305 
Although all three mechanisms allow RetS to downregulate GacS signalling, there 306 
are significant differences. For example, mechanism 3 blocks the 307 
autophosphorylation of GacS but it differs from mechanisms 1 & 2, as it is unable to 308 
dephosphorylate GacS-P. This is important because autophosphorylation is not the 309 
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only way of generating GacS-P, as LadS-P phosphorylates GacS46; GacS-P 310 
generated from LadS-P would be unaffected by mechanism 3 but could be targeted 311 
by mechanisms 1 and 2. 312 
How might the three different mechanisms be controlled? RetS has a 313 
periplasmic ligand binding domain that has been implicated in detecting kin-cell lysis 314 
but its ligand is currently unknown50,59,60. Ligand binding could regulate any of the 315 
three mechanisms, but in other SKs there is a strong precedent for it regulating the 316 
balance between kinase activity and transmitter phosphatase activity20. RetS lacks 317 
kinase activity but, following this precedent, transmitter phosphatase activity 318 
(mechanism 2) is very likely to be under ligand control. Mechanism 1 provides 319 
considerable potential for linkage to other signalling pathways, in particular the HptB 320 
signalling pathway. HptB is a single domain Hpt protein that relays phosphoryl 321 
groups from several hybrid kinases (PA1611, ErcS’ and SagS) to the output RR, 322 
HsbR, which indirectly controls motility and cyclic-di-GMP levels54,61,62. Analogous to 323 
how RetS serves as a phosphoacceptor for GacS-P in mechanism 1, RetS can also 324 
take phosphoryl groups from HptB-P61. This could provide a route for HptB signalling 325 
to downregulate mechanism 1, since when RetS is phosphorylated by HptB-P, then, 326 
until it has dephosphorylated, it will be unable to accept phosphoryl groups from 327 
GacS-P. This potential communication route would expand the number of SKs, and 328 
therefore the number of different signals, that could influence signalling by the GacS 329 
network. Aside from this HptB mediated link, PA1611 has been shown to interact 330 
directly with RetS51,52. In wild-type cells, PA1611 is expressed only at very low levels 331 
making the physiological relevance of this interaction uncertain51, however it has 332 
been found that overexpression of PA1611 using a multicopy plasmid expression 333 
vector, favours the interaction between PA1611 and RetS, and relieves GacS from 334 
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the inhibitory effects of RetS, suggesting that PA1611 sequesters RetS away from 335 
GacS51. The phenotypic data from PA1611 overexpression are consistent with a total 336 
loss of RetS function51,52, suggesting that the sequestration of RetS by PA1611 337 
blocks all three of the mechanisms by which RetS targets GacS.  338 
In conclusion, we have discovered extensive interactions between the GacS 339 
and RetS SKs that play a critical role in controlling the switch between acute and 340 
chronic infection. We have identified three distinct biochemical mechanisms and 341 
demonstrated their important roles in vivo and in insect and mouse infection models. 342 
The complexity of these mechanisms reflects the importance of the finely balanced 343 
decisions that the GacS network makes during infection. As these mechanisms 344 
involve highly conserved domains or sequence motifs, they are likely to be used by 345 
many other multikinase networks for signal integration and decision-making. 346 
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Methods 347 
Bacterial strains and growth conditions. Bacterial strains and plasmids are 348 
described in Supplementary Table 1. Unless otherwise stated bacteria were grown in 349 
LB broth at 37 °C. When used, M63 (2 g/L (NH4)2SO4, 13.6 g/L KH2PO4, and 0.5 350 
mg/L FeSO4) was supplemented with 1 mM MgSO4, 0.5 % Casamino Acids and 0.2 351 
% glucose. Antibiotics were used at the following concentrations: ampicillin 100 352 
µg/ml, kanamycin 25 µg/ml, tetracycline 50 µg/ml and gentamycin 25 µg/ml (E. coli) 353 
or 100 µg/ml (P. aeruginosa).   354 
Plasmid construction. Genes for overexpressing wild-type cytoplasmic portions of 355 
proteins were amplified from P. aeruginosa PAO1 genomic DNA using primers 356 
described in Supplementary Table 2. Point mutations were introduced using overlap 357 
extension PCR.  Wild-type genes and their mutant derivatives were cloned into the 358 
pQE60 expression plasmid which attaches a C-terminal 6xHis tag. The proteins were 359 
overexpressed and purified as previously described for other SKs63,64. Allelic 360 
exchange plasmids for in-frame deletion of genes in PAO1 or for introducing point 361 
mutations were constructed using primers described in Supplementary Table 2 using 362 
P. aeruginosa DNA as template. These constructs were cloned into pEX19Gm for 363 
allelic exchange with PAO165,66. 364 
Strain construction. In-frame gene deletions and allelic exchange of gene regions 365 
containing introduced point mutations were carried out by tri-parental mating using E. 366 
coli containing the mobilisation plasmid, pRK201367. Subsequent sucrose and 367 
gentamycin susceptibility tests were done to isolate potential mutants. Deletion 368 
mutants were checked via PCR using primers outside of the initial construct used to 369 
make the deletion. PCR products were sequenced to confirm mutations. Tetra-370 
primer PCR68 was used as a preliminary screen to identify strains containing desired 371 
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point mutations. Potential mutants were then checked by sequencing using PCR 372 
products obtained using primers outside of the original mutation construct.   373 
Autophosphorylation assays. Reactions were performed in TGMNKD buffer (10% 374 
(v/v) Glycerol, 150 mM NaCl, 50 mM Tris HCl, 1 mM DTT, 5 mM MgCl2, 50 mM KCl, 375 
pH 8.0) and initiated by addition of 2 mM [γ32P] ATP (3.7 GBq/mmol PerkinElmer). 376 
The reactions contained 5 μM GacS derivative and 20 μM RetS derivative (Fig. 1m-377 
n). The final reaction volume was 100 µl. 10 µl aliquots were taken at the indicated 378 
timepoints and quenched in 20 µl of 2x SDS loading dye (7.5% (w/v) SDS, 90 mM 379 
EDTA, 37.5 mM Tris pH 6.8, 37.5% Glycerol, and 3% β-mercaptoethanol). Samples 380 
were stored on ice and then analysed using SDS-PAGE (10% (w/v) polyacrylamide). 381 
Gels were exposed to phosphorscreens (Fuji) for 1 hour and then analysed using a 382 
Fujifilm FLA-7000 phosphorimager. The uncropped phosphorimages used to 383 
produce Fig. 1 and Supplementary Fig. 1 are shown in Supplementary Fig. 5&6. 384 
Pre-phosphorylation of GacS derivatives. GacSc, GacSc(HAQ) and GacSc(HDQ) 385 
were purified and then incubated with 2 mM [γ32P] ATP (3.7 GBq/mmol PerkinElmer) 386 
for 1 hour at 20 °C. The phosphorylated proteins were then diluted in lysis buffer and 387 
purified away from unincorporated ATP using a Ni-NTA column69,70.  388 
GacS-P dephosphorylation assays. Reaction tubes contained TGMNKD buffer 389 
and, where appropriate, RetSc or one of its mutant derivatives. The reactions were 390 
initiated by addition of phosphorylated GacS (either wild-type GacSc-P or one of its 391 
mutant derivatives). Reactions contained: 2 μM GacSc-P and 50 μM RetSc 392 
derivative (Fig. 1a-d and Supplementary Fig. 1a-c), 4 μM GacSc(HAQ)-P and 20 μM 393 
RetSc derivative (Fig. 1e-h and Supplementary Fig. 1d-f), 2 μM GacSc-P and 20 μM 394 
RetSc derivative (Fig. 1j,k), and 2 μM GacSc(HDQ)-P and 20 μM RetSc derivative 395 
(Supplementary Fig. 2). Reactions were performed at 20 oC. 10 µl samples were 396 
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taken at the timepoints indicated and processed as described for the 397 
autophosphorylation assays.  Half-times of GacSc-P dephosphorylation were 398 
calculated using Origin 4.1. Data were analysed using a One-Way ANOVA with 399 
Tukey’s modification. 400 
Biofilm formation. Biofilm formation was measured using the MBECTM (Minimum 401 
Biofilm Eradication Concentration) Assay from Innovotech. This features a 96-well 402 
plate with a peg lid and was used according to a modified method previously 403 
described71. Overnight LB cultures were standardised in LB broth to an OD600nm=1.0, 404 
which were then diluted 1:100 in M63. In each well, 150 µl of diluted culture or 405 
uninoculated broth was dispensed before the sterile peg lid was sealed on the plate. 406 
Each strain had 5 technical repeats per plate. The plates were incubated for 10 hrs 407 
at 37 °C with shaking at 125 rpm. Peg lids were removed and washed in PBS before 408 
being dried at 65 °C. Dried lids were stained with 0.1% (w/v) crystal violet. The pegs 409 
were washed 3 times in PBS, 5 minutes per wash, before bound crystal violet was 410 
solubilised in 95% ethanol. These plates were read at OD570nm. Three biological 411 
repeats were performed.  412 
RNA extraction, cDNA and qPCR. Overnight cultures were subcultured into LB 413 
broth with a starting OD600nm of 0.03 and incubated for 6 hrs at 37 °C with shaking. 414 
Cells were harvested and processed following the supplier’s protocol through the 415 
RiboPure Bacteria Kit (Ambion), which includes a DNA removal step, which was 416 
repeated twice. Purified RNA was checked by PCR for DNA contamination before 417 
cDNA was made using SuperScript III reverse Transcriptase (Life Technologies) 418 
following the supplier’s protocol. Quantitative real time PCR (qRT-PCR) was carried 419 
out on a Stratagene Mx3005P machine using Brilliant III Ultra-Fast SYBR Green 420 
qPCR kit (Agilent Technologies) following the manufacturer’s protocol.  The 421 
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oligonucleotides used are detailed in Supplementary Table 2. The housekeeping 422 
gene rpoC was used an internal control. Fold changes in expression were calculated 423 
using the 2-ΔΔCT method72. Data were analysed using a one-way ANOVA with 424 
contrasts. 425 
Swarming motility assay. Large swarming plates (140 mm) contained 0.5% (w/v) 426 
agar (LAB Agar No2 Bacteriological) and 8 g/L nutrient broth (Oxoid) supplemented 427 
with 0.5% (w/v) glucose. Plates were inoculated with 0.5 µl overnight culture, 428 
incubated at 20 °C for 2 hrs prior to incubation at 30 °C for 16 hrs. Plates were then 429 
incubated at 20 °C for a further 8 hours before imaging.  430 
Galleria mellonella infection model. Galleria larvae killing was performed based on 431 
a previously described assay73. Galleria larvae were obtained from UK Waxworms 432 
Ltd (Sheffield, UK). P. aeruginosa stains were grown overnight in M63 before being 433 
centrifuged, washed and resuspended in PBS to an OD590=1 ± 0.05. This was diluted 434 
5 x 105 fold in PBS. Using a gastight repeat dispenser Hamilton syringe, 2 X 5 µl of 435 
the diluted bacterial suspension (20-40 CFUs) were injected into the hindmost proleg 436 
of the larvae. Larvae were incubated at 37 °C and their survival was monitored after 437 
15 hours of incubation for up to 47 hours. Data were analysed using Kaplan-Meier 438 
survival curves. Statistical significance was assessed using the Mantel-Cox Log 439 
Rank test, applying Bonferroni’s correction for multiple comparisons.  440 
Mouse respiratory infection model. The mouse infection model was done as 441 
previously described74. 7-9 week old female Balb/c mice (Harlan) were anesthetized 442 
with O2 and isoflurane and infected intranasally with a challenge dose of 2x107 443 
CFUs. Two independent experiments were performed, each with five mice per strain.  444 
Power calculations were used to estimate the number of mice needed to detect a 10 445 
% change in the mean survival time. Mice were randomly assigned to each of the 446 
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treatment groups. No blinding was used. Survival was followed over 7 days and 447 
scored as previously described74. Mouse experiments were approved by the United 448 
Kingdom Home Office (Home Office Project License Number 40/3602) and the 449 
University of Liverpool Animal Welfare and Ethics Committee. 450 
Western Blot. Overnight LB cultures were standardised in LB broth to an 451 
OD600nm=1.0, which were then diluted 1:100 in M63. Cells were incubated for 10 hrs 452 
at 37 °C with shaking at 125 rpm. 1 ml of cells was centrifuged at 13,000 rpm. Cell 453 
pellets were resuspended in 100 µl of BugBuster (Merck) and incubated at 20 °C for 454 
20 minutes to lyse cells. 25 µl NuPAGE® LDS sample buffer (4X) (Invitrogen) was 455 
added and samples were boiled for 5 minutes at 100 °C. Whole cell lysates were 456 
separated using Bis-Tris NuPAGE® Novex® 4 to 12% SDS-PAGE gels (Invitrogen). 457 
Proteins were electrically transferred to a nitrocellulose membrane (Fisher) and 458 
blocked overnight at 4 °C using 3% (w/v) skimmed milk (Sigma) in TPBS (PBS 459 
supplemented with 1% (v/v) Tween-20). The membrane was incubated at 20 °C for 460 
30 mins before being incubated for 90 minutes with 3% (w/v) skimmed milk in TPBS 461 
with the primary antibody (rabbit) diluted 1:1000. The primary rabbit antibody was 462 
raised against the purified cytoplasmic portion of RetS (Eurogentec). The membrane 463 
was washed three times for 5 minutes in TPBS. It was then incubated for 90 minutes 464 
with a secondary antibody (goat anti-rabbit) with an infrared dye (IRDye® 800W 465 
secondary antibodies from Li-Cor) diluted 1:25000 in TPBS with 3% (w/v) skimmed 466 
milk. The membrane was washed three times for 5 minutes with TPBS and imaged 467 
on the Li-Cor Odyssey.      468 
Data availability 469 
The authors declare that the data supporting the findings of this study are available 470 
within the paper and its supplementary information files.  471 
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Figure legends 668 
Figure 1 | RetS downregulates GacS signalling via three distinct mechanisms. 669 
a-i, Mechanism 1 – RetS takes phosphoryl groups from GacS-P. Phosphorimages of 670 
SDS-PAGE gels showing phosphotransfer from (a-d) GacSc-P to (a) buffer control, 671 
(b) RetSc, (c) RetSc(HDA) and (d) RetSc(HAA), and from (e-h) GacSc(HAQ)-P to 672 
(e) buffer control, (f) RetSc, (g) RetSc(HDA) and (h) RetSc(HAA). Experiments were 673 
repeated 5 times and a representative image shown.  i, Cartoon depicting 674 
mechanism 1, where phosphotransfer occurs from the His residue in the HisKA 675 
domain of GacS to D858 in REC2 of RetS.  676 
j-l, Mechanism 2 - RetS has transmitter phosphatase activity against GacS-P. j, 677 
Phosphorimages of SDS-PAGE gels measuring the dephosphorylation of GacSc-P 678 
alone (top) and with RetSHK (bottom). k, GacS-P dephosphorylation half-times in the 679 
presence of various RetS mutant proteins. Error bars show SEM from 8 replicates. * 680 
significantly faster than GacSc-P autodephosphorylation (P < 0.05, one-way 681 
ANOVA). l, Cartoon depicting mechanism 2, where RetS uses transmitter 682 
phosphatase activity against the REC domain of GacS-P.  683 
m-o, Mechanism 3 - RetS inhibits the GacS autophosphorylation reaction. 684 
Phosphorimages of SDS-PAGE gels comparing the autophosphorylation of: (m) 685 
GacSc(HAQ) on its own (top), with RetSc(HAA) (middle), and with 686 
RetSc(T428A,HDA) (bottom). (n) GacSHK on its own (top) and with RetSHK (bottom). 687 
Experiments were repeated 8 times and a representative image shown. o, Cartoon 688 
depicting mechanism 3, where the catalytic core of RetS blocks the 689 
autophosphorylation of GacS. 690 
Figure 2 | Mechanisms 1 and 2 control biofilm formation and the expression 691 
levels of RsmY, while all three mechanisms contribute to controlling RsmZ 692 
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levels. a, Quantification of biofilm formation on peg-lidded 96-well plate by crystal 693 
violet staining. Plates inoculated with the mutant strains were incubated for 10 hrs 694 
with shaking at 37 °C. Error bars show SEM (three biological repeats each 695 
containing five technical repeats). * indicates significantly different comparisons (P < 696 
0.05, one-way ANOVA). See also Supplementary Fig. 4 for these mutations in a 697 
ΔgacS background. b,c, Relative expression level of RsmY (b) and RsmZ (c) in the 698 
mutant strains relative to the wild-type PAO1 strain. RNA levels were measured 699 
using qRT-PCR. Error bars show SEM (three biological repeats, with 3 technical 700 
repeats per biological repeat). * indicates significantly different comparisons (P 701 
<0.05, one-way ANOVA). The mechanisms disabled in each mutant strain are 702 
indicated. 703 
Figure 3 | Mechanism 1 is required for swarming motility. a-d, Representative 704 
images of the swarming of the wild-type PAO1 strain and its mutant derivatives. 705 
Experiments were repeated three times. The mechanisms disabled in each mutant 706 
strain are indicated in circles.  707 
Figure 4 | Mechanisms 1 and 2 are important for virulence in Galleria 708 
mellonella. 709 
a, Survival of G. mellonella larvae infected with the retS mutant strains.  * indicates 710 
strains showing significantly attenuated virulence compared to PAO1 (P < 0.01, 711 
Mantel-Cox Log Rank with Bonferroni’s correction for multiple comparisons). b, The 712 
retS point mutations have no phenotype in a ΔgacS background. * indicates strains 713 
showing significantly attenuated virulence compared to PAO1 (P < 0.01, Mantel-Cox 714 
Log Rank with Bonferroni’s correction for multiple comparisons). c, Complementation 715 
of the ΔretS mutant by overexpressing RetS(T428A,HDA). * significantly more 716 
virulent than the ΔretS-pJN105 strain (P < 0.01, Mantel-Cox Log Rank with 717 
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Bonferroni’s correction for multiple comparisons). a-c, The mechanisms absent from 718 
each strain are indicated in grey circles (except in the ΔgacS background strains that 719 
lack the target of these mechanisms). Three independent experiments were 720 
conducted each with 10 larvae per strain (30 larvae in total per mutant). The 721 
inoculum was 20-40 CFUs per larvae. 722 
Figure 5 | Mechanisms 1 and 2 are important for virulence in mice. Survival of 723 
mice infected intranasally with the retS mutant strains. Mice infected with the wild-724 
type PAO1 strain developed an acute respiratory infection. Two independent 725 
experiments were performed, each with 5 mice per mutant strain (10 mice per 726 
mutant strain). The inoculum was 2 x 107 CFUs per mouse. * indicates strains 727 
showing significantly attenuated virulence compared to PAO1 (P < 0.01, Mantel-Cox 728 
Log Rank with Bonferroni’s correction for multiple comparisons). The mechanisms 729 
absent from each strain are indicated in grey circles. 730 
Figure 6 | The three mechanisms used by RetS to inhibit GacS signalling. 731 
Mechanism 1 – D858 in REC2 of RetS takes the phosphoryl group from the 732 
autophosphorylatable His residue in the HisKA domain of GacS. Mechanism 2 – 733 
RetS uses its transmitter phosphatase activity to accelerate the dephosphorylation of 734 
the REC domain of GacS-P. Mechanism 3 – The catalytic core of RetS inhibits the 735 
GacS autophosphorylation reaction.  736 
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